Study on Musculoskeletal Disorders in Spanish Pianist

October 19, 2020 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Transversal Observational Study on Musculoskeletal Disorders in Spanish Pianist

Background: musculoskeletal disorders related to instrumental practice (TMRPI) affect many pianists.

Objectives: to know the prevalence of TMRPI in the population of Spanish pianists and its relationship with gender, age, physical activity, number of years playing the piano and the number of hours per week.

Design: transversal study based on a survey that included 30 volunteers of both genders, aged between 17 and 65, who played the piano for at least 2 years.

Method. due to the absence of specific questionnaires for pianist populations on MMRPI, a questionnaire was conducted combining a validated questionnaire on MMR, the Nordic Musculoskeletal Questionnaire (NMQ) with an "ad hoc" questionnaire created specifically for this study

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Avila, Spain, 05005
        • Universidad Católica de Ávila

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

professional pianists with musculoskeletal disorders

Description

Inclusion Criteria:

  • over 16 years old
  • at least 2 years playing piano

Exclusion Criteria:

  • Traumatism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessed by VAS Scale
Time Frame: 2 months
Pain assessed by VAS Scale
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
YEARS
Time Frame: 2 years
Incidence of pain over years of practice
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Actual)

July 10, 2020

Study Completion (Actual)

August 31, 2020

Study Registration Dates

First Submitted

October 13, 2020

First Submitted That Met QC Criteria

October 19, 2020

First Posted (Actual)

October 22, 2020

Study Record Updates

Last Update Posted (Actual)

October 22, 2020

Last Update Submitted That Met QC Criteria

October 19, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13/10/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

Clinical Trials on SURVEY

3
Subscribe